[23] Notably, an overproduction of IL-1α and IL-1β from resident liver cells is observed in the development of NASH, as a deficiency in either interleukin was observed to sufficiently protect against NASH development. Here, IL1B is linked to metabolic dysfunction-associated steatohepatitis.